Clinical trials
Hypoglycemia (Diabetic) clinical trials
Below are recruiting hypoglycemia (diabetic) clinical trials, each written for real people, not researchers. We’re tracking 34 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06473480Recruiting
Continuous glucose sensor vs. fingerstick in hospital patients
This study compares a continuous glucose monitor (a small sensor on the skin) with the usual fingerstick method for checking blood sugar in hospitalized patients. It aims to see if the sensor is more convenient and just as accurate.
Køge, KøgeAges 18–110 - NCT06575426RecruitingPhase 1/Phase 2
Pig pancreatic cell transplant for type 1 diabetes
This trial tests a new treatment made from pig pancreatic cells (called OPF-310) that are placed under the skin to help control blood sugar in people with type 1 diabetes. It is for those whose diabetes is difficult to manage and who have dangerous low blood sugar episodes.
Chicago, IllinoisAges 35–70 - NCT07094529Recruiting
Tailored low blood sugar treatment for type 2 diabetes
This study tests a personalized approach to treating low blood sugar (hypoglycemia) in adults with type 2 diabetes. It aims to find out if this tailored treatment plan is practical and helpful for people who take certain diabetes medications (sulfonylureas or insulin).
Ottawa, OntarioAges 18 years+ - NCT07726680Recruiting
Game for kids with new type 1 diabetes
This study tests a fun video game that connects to a continuous glucose monitor (CGM). The game helps kids newly diagnosed with type 1 diabetes learn about managing their condition in a playful way. Both the child and a parent need to join together.
Lahore, Punjab ProvinceAges 6–17 - NCT05762107RecruitingPhase 2
Drug ZT-01 to reduce low blood sugar at night
This Phase 2 study tests ZT-01 to help prevent night-time low blood sugar (hypoglycemia) in people with type 1 diabetes. It may help if you’ve had low blood sugar during sleep or are at high risk based on recent glucose monitoring.
Birmingham, AlabamaAges 18–75 - NCT06297980Recruiting
Periods, blood sugar, and exercise in type 1 diabetes
This study looks at how your menstrual cycle affects your blood sugar and how you respond to exercise if you have type 1 diabetes. It aims to help women manage their diabetes better throughout the month.
Aurora, ColoradoAges 18–45 - NCT07696273Recruiting
Breath test for detecting high and low blood sugar
This trial tests a new breath-based sensor to detect low or high blood sugar (hypoglycemia or hyperglycemia) in people with type 1 or type 2 diabetes. It might offer a non-invasive way to monitor glucose levels.
Indianapolis, IndianaAges 7–25 - NCT07329985Recruiting
Fear of low blood sugar in diabetes
This study looks at how afraid people with diabetes are of low blood sugar (hypoglycemia). It may help doctors understand your worries and improve care.
BilecikAges 18–65 - NCT05447806Recruiting
Diabetes decision help after an alert message
This study tests a computer system that helps clinicians make better diabetes decisions when an alert or disease-management message appears. It may help your care by guiding what actions the care team takes next.
Hershey, PennsylvaniaAges 18 years+ - NCT07286500Recruiting
Sex, diabetes, and low blood sugar risk
This study looks at how sexual activity affects blood sugar levels and the risk of low blood sugar (hypoglycemia) in adults with diabetes who use insulin and a continuous glucose monitor. By participating, you'll help researchers understand the safety of sexual activity for people with diabetes.
WarsawAges 18 years+ - NCT05221359Recruiting
Safety trial of ExOlin® for adults with hard-to-control type 1 diabetes
This trial checks whether ExOlin® is safe in adults with type 1 diabetes who have had difficult blood sugar control or injection-site skin problems despite insulin pump and continuous glucose monitoring. It’s mainly looking for safety and comfort while using the treatment devices.
StrasbourgAges 18 years+ - NCT06770621Recruiting
Glucagon response study in new type 1 diabetes
This study looks at how the body makes glucagon (a hormone that raises blood sugar) in children and teens with new type 1 diabetes. It aims to understand why some people may have dangerous low blood sugars, so doctors can better prevent them in the future.
Brussels, Woluwe-saint-lambertAges 2–30 - NCT05317455RecruitingEarly Phase 1
Studying brain sugar changes in adults with risky low blood sugar
This early-stage study looks at how the brain uses sugar in people with type 1 diabetes who have had severe or hard-to-notice low blood sugar. It may help researchers understand the brain effects of low blood sugar and guide safer care.
New Haven, ConnecticutAges 18–55 - NCT06296485Recruiting
Safer Aging with Diabetes Monitoring
This study tests a way to help older adults with type 2 diabetes who use insulin avoid dangerously low blood sugar. You would use a continuous glucose monitor and get support via email or internet to stay safe.
Fremont, CaliforniaAges 75 years+ - NCT06234787Recruiting
Continuous glucose monitoring in ICU patients
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
MadridAges 18 years+ - NCT06468865Recruiting
Glucose monitoring for low blood sugar after gastric bypass
This trial tests whether a new way of using glucose monitoring can help manage low blood sugar that happens after meals in people who have had gastric bypass surgery. It aims to find better ways to track and treat these episodes.
Tønsberg, VestfoldAges 18 years+ - NCT07814508Recruiting
Continuous glucose monitor app study for insulin users
This study tests a new continuous glucose monitor (CGM) system with a predictive app to help people on insulin therapy manage their blood sugar better. It aims to see if the app improves daily life and glucose control.
Bad Mergentheim, Baden-WurttembergAges 18 years+ - NCT07503028Enrolling by invitationEarly Phase 1
Stem cell therapy for severe low blood sugar in diabetes
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
Hefei, AnhuiAges 18–70 - NCT06683391Recruiting
Improving Low Blood Sugar Guidelines for Type 1 Diabetes
This study is looking for adults with type 1 diabetes to help improve guidelines for preventing and treating low blood sugar (hypoglycemia). The goal is to make recommendations that are more practical and safer for people like you.
Montreal, QuebecAges 18 years+ - NCT06893341Recruiting
Breath Device to Detect Blood Sugar Changes in Teens
This study tests if a breath device can spot high or low blood sugar in teens with type 1 diabetes without a fingerstick. Participants will use the device a few times and share their CGM data.
Indianapolis, IndianaAges 12–19 - NCT04657783Recruiting
French cohort study of people with type 1 diabetes
This study follows people with type 1 diabetes in France to better understand the condition over time. It may help researchers improve future care, especially for how type 1 diabetes starts and is managed from early diagnosis onward.
ParisAges 6–100 - NCT07212075Recruiting
Digital twin study for mental health in diabetes
This study uses digital twins—a virtual model of your health—to track how your mental health changes with diabetes. It aims to find patterns that could help personalize mental health care.
Bad Mergentheim, Baden-WurttembergAges 18–80 - NCT06470295RecruitingEarly Phase 1
C-peptide's effect on low blood sugar response
This study tests whether C-peptide (a substance made by the pancreas) can help your body respond better to low blood sugar (hypoglycemia). It's a very early trial for people without certain health conditions.
Cincinnati, OhioAges 18–40 - NCT06325202Recruiting
A study on preventing low blood sugar with a closed loop system
This trial tests whether a closed-loop insulin pump combined with education can help people with type 1 diabetes better recognize and avoid dangerously low blood sugar. It may be a good fit if you've had diabetes for a long time and have trouble sensing when your blood sugar drops.
La Jolla, CaliforniaAges 18–75
Hear when a new Hypoglycemia (Diabetic) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hypoglycemia (diabetic)?
- Yes. Clin2 currently lists 34 recruiting hypoglycemia (diabetic) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hypoglycemia (diabetic) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hypoglycemia (diabetic) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.